Department of Paediatric Cardiology and Cardiac Surgery, Bambino Gesù Children's Hospital, IRCCS, Sant'Onofrio 4, 00165 Rome, Italy.
Genetics and Rare Diseases Research Division, Unit of Metabolism, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Europace. 2021 Jun 7;23(6):948-957. doi: 10.1093/europace/euaa335.
The aims of this study are to evaluate the progressive involvement of the cardiac conduction system in the Kearn-Sayre syndrome (KSS) and to establish criteria for the prevention of episodes of syncope or sudden cardiac death.
This is a prospective monocentric study including KSS patients, with diagnosis based on clinical manifestations, muscle biopsy, and genetic tests, before the age of 18. All patients underwent cardiac screening examination with 12-lead electrocardiogram (ECG), 24-h Holter monitoring, and pacemaker (PM) interrogation twice a year. Fifteen patients (nine males, mean age 16.6 ± 3.9 years) with a sporadic KSS were recruited. All subjects manifested at least one of the intraventricular conduction defects (IVDs): 1 right bundle branch block (RBBB), 2 left anterior fascicular block (LAFB), 11 a bi-fascicular block (RBBB + LAFB), and 1 left posterior fascicular block. Most children with bi-fascicular block developed LAFB before the RBBB (P = 0.0049). In six patients, IVD degenerated into atrioventricular block (AVB). Endocavitary PM was implanted in 11 patients (6 with AVB and 5 with a bi-fascicular block), while an implantable cardioverter-defibrillator only in one patient with a non-sustained ventricular tachycardia. Four died at mean age of 14.7 ± 2.6 years, but none of them suddenly.
Even a 'simple' ECG can predict the arrhythmic risk and the occurrence of catastrophic events in young patients with KSS. Left anterior fascicular block precedes RBBB in determining the bi-fascicular block and this can predict an inexorable progression of the conduction defects even in a short time. Pacemaker implantation may be indicated in these patients since the first bi-fascicular block manifestation.
本研究旨在评估心脏传导系统在 Kearn-Sayre 综合征(KSS)中的渐进性累及,并为预防晕厥或心源性猝死发作确立标准。
这是一项前瞻性单中心研究,纳入 KSS 患者,诊断依据为临床表现、肌肉活检和基因检测,年龄均在 18 岁之前。所有患者每年接受 2 次 12 导联心电图(ECG)、24 小时动态心电图监测和起搏器(PM)询问检查。共纳入 15 例散发性 KSS 患者(9 例男性,平均年龄 16.6±3.9 岁)。所有患者至少存在 1 种室内传导障碍(IVD):1 例右束支传导阻滞(RBBB),2 例左前分支阻滞(LAFB),11 例双分支阻滞(RBBB+LAFB),1 例左后分支阻滞。大多数双分支阻滞患儿先出现 LAFB,然后出现 RBBB(P=0.0049)。6 例 IVD 进展为房室传导阻滞(AVB)。11 例患者(6 例伴 AVB,5 例伴双分支阻滞)植入心内膜 PM,1 例非持续性室性心动过速患者植入植入式心律转复除颤器。平均随访 14.7±2.6 年后 4 例死亡,但均非猝死。
即使是“简单”的心电图也可以预测 KSS 年轻患者的心律失常风险和灾难性事件的发生。LAFB 先于 RBBB 出现可预测双分支阻滞,即使在短时间内也可预测传导障碍的不可避免进展。这些患者首次出现双分支阻滞时,可能需要植入起搏器。